MAC Clinical Research now incorporated in Australia
To continue to meet the research needs of our clients and their patients across the globe, MAC Clinical Research has arrived in Australia! As a
May 3, 2023
To continue to meet the research needs of our clients and their patients across the globe, MAC Clinical Research has arrived in Australia! As a
MAC enters partnership with Kariya Pharmaceuticals with the commencement of Phase I trial for Parkinson’s drug. We are excited to partner with Kariya Pharmaceuticals, a
Parkinson’s disease (PD) is a progressive movement disorder of the nervous system. Like a fingerprint, disease presentation is different in every person who receives a
At MAC, we welcome the recent update from the MHRA announcing that they will streamline clinical trial approvals in its biggest overhaul in 20 years.
Martyn Deverell, Principal SAS Programmer at MAC Clinical Research will be speaking at the 2023 CDISC Europe Interchange taking place in Copenhagen on 26 -27
As part of Rare Disease Day 2023, we want to highlight the work we are doing in Sickle cell disease. Sickle cell disease is the
We are excited to share that our Early Phase Unit in Manchester dosed the first participant in Small Pharma’s first-in-human Phase I clinical trial of
We’re proud to share that Hannah Gillis, Head of Data Management has been selected as a finalist for this year’s ACDM awards. She is one
In recognition of the International Day of Women and Girls in Science on February 11th, I had the opportunity to attend The 8th International Day
The placebo response or the placebo effect. We hear about it a lot, but what happens in practise? Let’s unravel it by understanding what it